jiayi-li23/proxann_data huggingface dataset:
Bill 112-HR-3721 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Servicemember Assistance for Lawful Understanding, Treatment, and Education Act or the SALUTE Act - Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants for veterans' treatment courts and programs for continuing judicial supervision over offenders who are veterans. Requires such grants to be used for: (1) developing, implementing, or enhancing veterans' treatment courts or expanding operational mental health or drug courts to serve veterans to ensure that such courts effectively integrate substance abuse treatment, mental health treatment, sanctions and incentives, and transitional services in a judicially supervised court setting with jurisdiction over offenders that have served in the U.S. military; and (2) programs that involve continuing judicial supervision over offenders with substance abuse or mental health problems who have served in the U.S. military and the integrated administration of other sanctions and services, which shall include substance abuse and mental health treatment for each participant and diversion, probation, or other supervised release involving the possibility of prosecution, confinement, or incarceration based on noncompliance with program requirements or failure to show satisfactory progress. Requires an evaluation report submited by a state, Indian tribal government, or local government that receives funds under such Act to include data on and an evaluation of the effectiveness of veterans' treatment courts and programs.
Bill 112-HR-3724 — Health / Drug and Alcohol Abuse
Subject: Health

Medical Controlled Substances Transportation Act of 2011 - Amends the Controlled Substances Act to authorize a physician registered to dispense, or conduct research with, schedule II, III, IV, or V controlled substances to enter into an agreement with the Attorney General that authorizes the physician to transport controlled substances from a practice setting to another practice setting or to a disaster area and that requires the physician to: (1) notify the Attorney General in advance of any such transport; (2) identify the controlled substances to be transported, the areas from which and to which the substances will be transported, and the intended dates, mode, time, and duration (not to exceed 72 hours) of transport; and (3) maintain records in the physician's primary practice setting on the dispensing of any substance transported.
Bill 112-HR-3810 — Health / Drug and Alcohol Abuse
Subject: Transportation and public works

Amends the federal-aid highway program to modify the minimum penalties states are required to impose on motorists convicted multiple times for driving while intoxicated or under the influence of alcohol. Requires repeat offenders to have: (1) all their driving privileges suspended (currently, a driver's license suspension) for at least one year; or (2) their unlimited driving privileges suspended for one year, with limited driving privileges permitted, subject to restrictions and limited exemptions established under state law, if an ignition interlock device is installed for at least one year on each of the motor vehicles they own or operate. Eliminates the current alternative of a combination of suspension of all driving privileges for the first 45 days of the suspension period followed by a reinstatement of limited driving privileges for the purpose of getting to and from work, school, or an alcohol treatment program if an ignition interlock device is installed on each of the motor vehicles owned or operated, or both, by the individual.
Bill 112-HR-4205 — Health / Drug and Alcohol Abuse
Subject: Health

Synthetics are Dangerous Act - Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to: (1) include among the purposes of the national youth anti-drug media campaign to encourage parents and other interested adults to discuss with young people the dangers of synthetic drug use; (2) define "drug" for purposes of such campaign to be a controlled substance, including a synthetic drug; and (3) define a "synthetic drug" as an artificially produced substance that is an analog or derivative of a controlled substance but is not itself a controlled substance.
Bill 112-HR-4292 — Health / Drug and Alcohol Abuse
Subject: Health

Interstate Drug Monitoring Efficiency and Data Sharing Act of 2012 or the ID MEDS Act - Directs the Attorney General to establish national interoperability standards to facilitate the exchange of prescription information by states receiving grant funds under the Harold Rogers Prescription Drug Monitoring Program (Rogers Program) and the Controlled Substance Monitoring Program (CS Program). Directs the Attorney General to ensure that such standards: (1) implement open standards that are freely available to promote broad implementation; (2) provide for the use of exchange intermediaries to facilitate interstate interoperability; (3) support transmissions that are fully secured, using industry standard methods of encryption, to ensure that protected health information and personally identifiable information are not compromised during transmission; and (4) employ access control methodologies to share protected information solely in accordance with state laws and regulations. Requires a grant recipient under the Rogers Program to ensure that the state databases comply with the national interoperability standards. Allows a recipient of an enhancement grant under such Program to use grant funds to standardize the technology architecture used by the recipient to comply with such standards. Amends the Public Health Service Act to require states to ensure that databases established under the CS Program comply with such standards. Directs the Attorney General to report on enhancing the interoperability of state prescription monitoring programs with other technologies and databases used for detecting and reducing fraud, diversion, and abuse of prescription drugs.
Bill 112-HR-6311 — Health / Drug and Alcohol Abuse
Subject: Health

Stop Overdose Stat Act or the S.O.S. Act - Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses, and (2) give priority to eligible public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations. Conditions receipt of a grant or agreement on an entity agreeing to use the grant or agreement for: (1) purchasing and distributing the drug naloxone; (2) educating physicians and pharmacists about overdose prevention and naloxone prescription; (3) training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response; (4) implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response to individuals in need; and (5) expanding such programs. Requires the Director to: (1) compile and publish, annually, data on fatal and nonfatal drug overdoses for the preceding year; and (2) award grants to state, local, or tribal governments, or the National Poison Data System working in conjunction with such governments, to improve drug overdose surveillance and reporting capabilities. Requires the Secretary of Health and Human Services (HHS) to develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses. Requires the Director of the National Institute on Drug Abuse (NIDA) to: (1) prioritize and conduct or support research on drug overdose and overdose prevention, and (2) support research on the development of dosage forms of naloxone for the prehospital treatment of unintentional drug overdose.
Bill 112-S-296 — Health / Drug and Alcohol Abuse
Subject: Health

Preserving Access to Life-Saving Medications Act - Amends the Federal Food, Drug, and Cosmetic Act to require a prescription drug manufacturer to notify the Secretary of Health and Human Services (HHS) of a discontinuance, interruption, or other adjustment of the manufacture of the drug that would likely result in a shortage of such drug. Requires: (1) six months notice of any discontinuance or planned interruption or adjustment, and (2) notice as soon as practicable after becoming aware of such interruption or adjustment in the case of any other interruption or adjustment. Applies this Act to any approved prescription drug that is not a product that was originally derived from human tissue and was replaced by a recombinant product. Sets forth the types of adjustment for which a manufacturer must submit notice, including: (1) adjustments related to the supply of raw materials, (2) adjustments to production capabilities, (3) business decisions that may affect the manufacture of the drug, and (4) other adjustments as determined appropriate by the Secretary.
Bill 112-S-510 — Health / Drug and Alcohol Abuse
Subject: Transportation and public works

Research of Alcohol Detection Systems for Stopping Alcohol-related Fatalities Everywhere Act of 2011 or ROADS SAFE Act of 2011 - Directs the Administrator of the National Highway Traffic Safety Administration (NHTSA) to carry out a collaborative research effort to continue to explore the feasibility and the potential benefits of, and the public policy challenges associated with, more widespread deployment of in-vehicle technology to prevent alcohol-impaired driving.
Bill 112-S-854 — Health / Drug and Alcohol Abuse
Subject: Health

Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act - Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2012-FY2016. Makes revisions to such program, including by: (1) revising reporting requirements on state programs on underage drinking; (2) expanding the national media campaign to prevent underage drinking; (3) requiring the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students; and (4) expanding state public health surveillance of alcohol use and alcohol-related conditions among individuals between the ages of 18 and 20.
Bill 112-S-2159 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Amends the National Narcotics Leadership Act of 1988 to authorize appropriations for the Drug-Free Communities Support Program for FY2013-FY2017. Requires the Director of the Office of National Drug Control Policy, in carrying out such Program, to ensure that: (1) each recipient of an initial or renewal grant meets the grant eligibility criteria for each fiscal year, and (2) the meeting of that criteria is fully documented. Requires the Director, upon delegating authority to the Substance Abuse and Mental Health Services Administration (SAMHSA) to carry out Program activities, to: (1) develop and document an approach to monitoring and overseeing the administration of the Program by SAMHSA, and (2) fully define the respective roles and responsibilities of the Office and SAMHSA in administering the Program. Authorizes the Director to make a grant to an eligible organization to provide for the establishment of a National Community Anti-Drug Coalition Institute to: (1) provide education, training, and technical assistance for coalition leaders and community teams, with emphasis on the development of coalitions serving economically disadvantaged areas; (2) develop and disseminate evaluation tools, mechanisms, and measures to better assess and document coalition performance measures and outcomes; and (3) bridge the gap between research and practice by translating knowledge from research into practical information.
Bill 112-S-2262 — Health / Drug and Alcohol Abuse
Subject: Health

Advancing FASD Research, Prevention, and Services Act - Amends the Public Health Service Act to revise and extend the Fetal Alcohol Spectrum Disorders (FASD) programs (as renamed under this Act, previously the Fetal Alcohol Syndrome and Fetal Alcohol Effect programs). Directs the Secretary of Health and Human Services (HHS) to: (1) establish and carry out a research agenda for FASD; (2) facilitate surveillance, public health research, and prevention of FASD; and (3) continue the Interagency Coordinating Committee on Fetal Alcohol Syndrome. Requires the Secretary to provide financial assistance to: (1) establish or expand state FASD programs; (2) implement best practices to educate children with FASD, educate members of the criminal justice system on FASD, and educate adoption or foster care agency officials about services for children with FASD; (3) provide transitional services for those affected by prenatal alcohol exposure; (4) develop public service announcements to raise awareness of the risks associated with alcohol consumption during pregnancy; (5) increase awareness and identification of FASD in federally qualified health centers; and (6) provide respite care for caretakers, recruit mentors, and provide educational and supportive services to families of individuals with FASD. Directs the Comptroller General (GAO) to make recommendations regarding the appropriate roles and responsibilities of federal entities with respect to programs and activities related to FASD. Requires the Secretary of Education to direct the Office of Special Education and Rehabilitative Services to conduct training on FASD surveillance and disseminate best practices in the education and support of children with FASD. Requires the Attorney General (DOJ) to direct the Office of Juvenile Justice and Delinquency Prevention to: (1) implement FASD screening procedures, (2) conduct training on surveillance and on identification and support of individuals with FASD, and (3) study the inadequacies of the current system.
Bill 113-HR-498 — Health / Drug and Alcohol Abuse
Subject: Health

Sober Truth on Preventing Underage Drinking Reauthorization Act or STOP Act - Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2014-FY2018.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Secretary of Health and Human Services (HHS) to collect data and conduct or support new research on underage drinking that improves and conducts public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.
Bill 113-HR-672 — Health / Drug and Alcohol Abuse
Subject: Health

Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.
Bill 113-HR-2130 — Health / Drug and Alcohol Abuse
Subject: Health

Access to Substance Abuse Treatment Act of 2013 - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to make grants to: (1) increase the availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP); (2) provide vouchers to individuals in underserved populations for authorized services related to such treatment; and (3) establish programs to provide for and coordinate the provision of wrap-around services, such as medical services, job training services, and housing assistance, to individuals re-entering the community after successfully receiving treatment for abuse of such substances.

Revises the grant program to provide residential substance abuse treatment to pregnant and postpartum women to: (1) make caregiver parents eligible for such program, (2) make Indian tribes and tribal organizations eligible for grants, and (3) set forth the priority for allocation of grants.

Requires the Director of the National Institute on Drug Abuse to conduct research on the effectiveness of the use of agonist and antagonist drugs to reduce the problems associated with stimulant abuse, including cocaine and methamphetamine abuse.

Requires the Secretary to seek to enter into a contract with the Institute of Medicine to complete a literature review on the effectiveness of agonist and antagonist drugs for the treatment of stimulant abuse, including cocaine and methamphetamine abuse.

Requires the Comptroller General to study: (1) the impact of the programs authorized by this Act on the effectiveness and availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine; (2) how the level of federal funding available for such treatment compares to the amount necessary to provide adequate treatment; and (3) the impact of effective treatment on cost savings due to the reduced need for criminal justice and other services.

 Declares that this Act shall not be construed to increase the amount of appropriations that are authorized to be approved for any fiscal year.
Bill 113-HR-2148 — Health / Drug and Alcohol Abuse
Subject: Health

Synthetics are Dangerous Act of 2013 - Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to: (1) include among the purposes of the national youth anti-drug media campaign to encourage parents and other interested adults to discuss with young people the dangers of synthetic drug use; (2) define "drug" for purposes of such campaign to be a controlled substance, including a synthetic drug; and (3) define a "synthetic drug" as an artificially produced substance that is an analog or derivative of a controlled substance but is not itself a controlled substance.
Bill 113-HR-2914 — Health / Drug and Alcohol Abuse
Subject: Health

Promoting Integrity in Medicare Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship.

Removes from the in-office ancillary services (IOAS) exception to such prohibitions certain services the Secretary of Health and Human Services (HHS) determines are not usually provided and completed during the visit to a physician's office in which such a service is determined to be necessary (non-ancillary services). (Thus subjects such non-ancillary services to the prohibitions against physician self-referrals).

Lists among specified non-ancillary services: (1) anatomic pathology services (including the technical or professional component of surgical pathology, cytopathology, hematology, blood banking, and pathology consultation and clinical laboratory interpretation services), (2) radiation therapy services and supplies, (3) advanced diagnostic imaging studies, and (4) physical therapy services.

Increases from a maximum of $15,000 to a maximum of $25,000 the civil monetary penalty in the case of a bill or claim for such services whose presenter knows or should have known they are for a service for which payment may not be made.

Increases from a maximum of $100,000 to a maximum of $150,000 the civil monetary penalty for any circumventive arrangement or scheme which a physician or other entity enters into knowing (or should know) has a principal purpose of assuring referrals by the physician to a particular entity which, if the physician directly made referrals to such entity, would be in violation of SSA title XVIII.

Directs the Secretary to review compliance with the self-referral prohibitions with respect to referrals for specified non-ancillary services in accordance with procedures established by the Secretary.

States that, in applying the self-referral prohibitions, the term "entity" includes a physician's practice when it bills under Medicare for the technical component or the professional component of a specified non-ancillary service.
Bill 113-HR-3454 — Health / Drug and Alcohol Abuse
Subject: Labor and employment

Ensuring Quality in the Unemployment Insurance Program (EQUIP) Act - Amends title III (Grants to States for Unemployment Compensation Administration) of the Social Security Act (SSA) to require state unemployment compensation (UC) laws to require, as a condition of UC eligibility for a benefit year, an applicant, before receiving any UC, to: (1) complete a substance abuse risk assessment; and (2) test negative for controlled substances within one week after the results of such assessment if the state determines that the applicant is a high-risk. Prescribes retesting requirements and UC payment suspensions for applicants who test positive.

Amends SSA title XVIII (Medicare) and the Patient Protection and Affordable Care Act to provide funding for such substance abuse testing out of current funds appropriated for the Independent Payment Advisory Board (IPAB) and, after application of those funds, for the Consumer Operated and Oriented Plan (CO-OP) program.